1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Spain Pharmaceuticals and Healthcare Report Q2 2016

Spain Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 81 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: EUR25.15bn (USD27.70bn) in 2015 to EUR25.61bn (USD27.40bn) in 2016;+1.7% in local currency terms and -1.1% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: EUR90.80bn (USD99.88bn) in 2015 to EUR92.56bn (USD99.04bn) in 2016; +1.9% in localcurrency terms and -0.8% in US dollar terms. Forecast revised downwards slightly from last quarter.

Table Of Contents

Spain Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Spain 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Spain 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Spain 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 24
OTC Drug Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Spain 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Spain 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Spain 2014-2020) 28
Pharmaceuticals and Healthcare Risk/Reward Index 29
Western Europe Risk/Reward Index 29
Spain Risk/Reward Index 34
Rewards 34
Risks 34
Regulatory Review 36
Intellectual Property Issues 37
Parallel Trade 38
OTC Medicines 39
Generic Medicines 40
Pricing Regime 40
Reference Pricing System 42
Reimbursement Regime 45
Market Overview 46
Epidemiology 47
Healthcare Sector 49
Table: Regional Public Hospital Debt - Values In EURmn 50
Table: Healthcare Resources (Spain 2010-2015) 52
Table: Healthcare Personnel (Spain 2010-2015) 52
Table: Healthcare Activity (Spain 2010-2015) 53
Research and Development 53
Clinical Trials 54
Competitive Landscape 56
Research Based Industry 56
Generic Drug Sector 57
Table: Multinational Market Activity 58
Biotechnology Sector 59
Pharmaceutical Retail 61
Company Profile 64
Almirall 64
Esteve 67
Demographic Forecast 70
Demographic Outlook 70
Table: Population Headline Indicators (Spain 1990-2025) 71
Table: Key Population Ratios (Spain 1990-2025) 71
Table: Urban/Rural Population and Life Expectancy (Spain 1990-2025) 72
Table: Population By Age Group (Spain 1990-2025) 72
Table: Population By Age Group % (Spain 1990-2025) 73
Glossary 75
Methodology 77
Pharmaceutical Expenditure Forecast Model 77
Healthcare Expenditure Forecast Model 77
Notes On Methodology 78
Risk/Reward Index Methodology 79
Index Overview 80
Table: Pharmaceutical Risk/Reward Index Indicators 80
Indicator Weightings 81

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.